Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WOCKHARDT   ACTAVIS
EQUITY SHARE DATA
    WOCKHARDT
Mar-23
ACTAVIS
Dec-18
WOCKHARDT/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs31616,126-   
Low Rs14510,818-   
Sales per share (Unadj.) Rs184.03,955.8-  
Earnings per share (Unadj.) Rs-43.1-1,274.2-  
Cash flow per share (Unadj.) Rs-25.7416.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs231.716,315.7-  
Shares outstanding (eoy) m144.09332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.33.4 36.8%   
Avg P/E ratio x-5.3-10.6 50.6%  
P/CF ratio (eoy) x-9.032.3 -27.8%  
Price / Book Value ratio x1.00.8 120.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m33,2024,480,758 0.7%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m6,3700-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m26,5101,315,689 2.0%  
Other income Rs m1,22025,160 4.8%   
Total revenues Rs m27,7301,340,849 2.1%   
Gross profit Rs m-1,93034,478 -5.6%  
Depreciation Rs m2,510562,428 0.4%   
Interest Rs m3,02075,923 4.0%   
Profit before tax Rs m-6,240-578,713 1.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m-30-7,334 0.4%   
Profit after tax Rs m-6,210-423,784 1.5%  
Gross profit margin %-7.32.6 -277.8%  
Effective tax rate %0.51.3 37.9%   
Net profit margin %-23.4-32.2 72.7%  
BALANCE SHEET DATA
Current assets Rs m19,140539,627 3.5%   
Current liabilities Rs m34,350477,372 7.2%   
Net working cap to sales %-57.44.7 -1,212.5%  
Current ratio x0.61.1 49.3%  
Inventory Days Days3920 201.1%  
Debtors Days Days1166 16.5%  
Net fixed assets Rs m48,670148,929 32.7%   
Share capital Rs m7200-   
"Free" reserves Rs m32,6600-   
Net worth Rs m33,3805,426,601 0.6%   
Long term debt Rs m2,2401,910,903 0.1%   
Total assets Rs m70,7508,483,012 0.8%  
Interest coverage x-1.1-6.6 16.1%   
Debt to equity ratio x0.10.4 19.1%  
Sales to assets ratio x0.40.2 241.6%   
Return on assets %-4.5-4.1 110.0%  
Return on equity %-18.6-7.8 238.2%  
Return on capital %-9.0-4.8 186.7%  
Exports to sales %00-   
Imports to sales %3.50-   
Net fx Rs m-1900-   
CASH FLOW
From Operations Rs m1,530470,046 0.3%  
From Investments Rs m-1,250258,229 -0.5%  
From Financial Activity Rs m-3,150-806,740 0.4%  
Net Cashflow Rs m-2,800-78,073 3.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare WOCKHARDT With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare WOCKHARDT With: MANGALAM DRUGS  GUJ.TERC LAB  BANDARAM PHARMA PACKTECH  JAGSON PHAR  PARMAX PHARMA  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.